News about Engineering

NPPA seeks PTR & MAT value for 29 formulations from drug manufacturers & marketers to fix ceiling prices

NPPA seeks PTR & MAT value for 29 formulations from drug manufacturers & marketers to fix ceiling prices

The National Pharmaceutical Pricing Authority (NPPA) has asked drug manufacturers and marketers to furnish the information relating to price to retailer (PTR) and moving annual turnover (MAT) in value term for about 29 NLEM formulations for the month of March 2021. The information will be used by NPPA for fixing ceiling price of the formulations

Engineering | 13/07/2021 | By Darshana 366

Seegene partners with Bio-Rad Labs to develop and commercialize diagnostic test products for US market

Seegene partners with Bio-Rad Labs to develop and commercialize diagnostic test products for US market

Seegene announced on June 1 the signing of an agreement with Bio-Rad Laboratories, Inc. to develop and commercialize products for molecular diagnostics of infectious diseases. Under the terms of the agreement, Seegene will provide diagnostic tests for use in Bio-Rad's CFX96 Dx Real-Time PCR System for the United States market

Engineering | 08/07/2021 | By Darshana 243

Labcorp introduces companion diagnostic for Amgen's new lung cancer therapy, Lumakras

Labcorp introduces companion diagnostic for Amgen's new lung cancer therapy, Lumakras

Labcorp, a leading global life sciences company, announced the availability of therascreen KRAS PCR Mutation Analysis, a companion diagnostic to identify patients with non-small cell lung cancer (NSCLC) who are eligible for treatment with Lumakras (sotorasib), a new treatment option developed by Amgen

Engineering | 05/07/2021 | By Darshana 179

Philips to develop magnetic resonance imaging technique to revolutionize MR imaging use in cardiology

Philips to develop magnetic resonance imaging technique to revolutionize MR imaging use in cardiology

Royal Philips, a global leader in health technology, has participated in an important research project to develop a magnetic resonance (MR) imaging technique that could potentially revolutionize the use of MR imaging in cardiology

Engineering | 03/07/2021 | By Darshana 228

ATAL Faculty Development Programme deliberate on novel ideas in drug design and engineering

ATAL Faculty Development Programme deliberate on novel ideas in drug design and engineering

The programme was jointly organized by Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR) and Delhi Pharmaceutical Sciences and Research University (DPSRU) in which lectures were delivered by prominent scientists from around the country in the field of pharmaceutical sciences

Engineering | 29/06/2021 | By Darshana 305

Wipro GE Healthcare begins local manufacturing of Versana ultrasound range in India

Wipro GE Healthcare begins local manufacturing of Versana ultrasound range in India

Wipro GE Healthcare, one of the leading Ultrasound manufacturers in India, has enhanced its local capability to manufacture a wide range of Versana products in India. This is as part of the company's strategy to expand localization and strengthen the supplier ecosystem. The Versana Ultrsound range is part of the company's affordable product portfolio

Engineering | 23/06/2021 | By Darshana 243

Cleveland Clinic research identifies link between gut microbes and stroke

Cleveland Clinic research identifies link between gut microbes and stroke

New findings from researchers at Cleveland Clinic, a top American hospital, show for the first time that the gut microbiome impacts stroke severity and functional impairment following stroke. The results, published in Cell Host & Microbe, lay the groundwork for potential new interventions to help treat or prevent stroke

Engineering | 22/06/2021 | By Darshana 265

Janssen announces positive results from phase 3 GLOW study of fixed-duration Imbruvica plus venetoclax compared to Clb+O to treat elderly or unfit patients

Janssen announces positive results from phase 3 GLOW study of fixed-duration Imbruvica plus venetoclax compared to Clb+O to treat elderly or unfit patients

The Janssen Pharmaceutical Companies of Johnson & Johnson announced primary results from the pivotal phase 3 GLOW study (NCT03462719) evaluating fixed-duration Imbruvica plus venetoclax (I+V) compared to chlorambucil plus obinutuzumab (Clb+O) for first-line treatment of elderly or unfit patients with chronic lymphocytic leukemia (CLL)

Engineering | 14/06/2021 | By Darshana 275

CSIR-CDRI signs agreement with Marc Labs to develop drug for heart attack and stroke

CSIR-CDRI signs agreement with Marc Labs to develop drug for heart attack and stroke

The agreement has been signed for the development of a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen induced platelet aggregation. This may be helpful in treating patient population of coronary and cerebral artery diseases

Engineering | 12/06/2021 | By Darshana 369

CSIR-IICT, Lee Pharma sign agreement to produce 2-D

CSIR-IICT, Lee Pharma sign agreement to produce 2-D

Lee Pharma has entered into a non-exclusive licensing agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-Deoxy-D-Glucose (2-DG) recently developed by DRDO and Dr Reddy's Laboratories to treat COVID patients, informed a statement

Engineering | 11/06/2021 | By Darshana 202

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members